EMA Recommends EU Approval of Revolution Medicines’ Pancreatic Cancer Drug
The European Medicines Agency recommended approval of Revolution Medicines’ Rasonque in the EU.
On Thursday, the European Medicines Agency recommended that the EU approve Revolution Medicines' pancreatic cancer drug Rasonque.